Cargando…
In Vivo Performance and Properties of Tamoxifen Metabolites for CreERT2 Control
Mutant Estrogen Receptor (ERT2) ligand-binding domain fusions with Cre recombinase are a key tool for spatio-temporally controlled genetic recombination with the Cre/lox system. CreERT2 is efficiently activated in a concentration-dependent manner by the Tamoxifen metabolite trans-4-OH-Tamoxifen (tra...
Autores principales: | Felker, Anastasia, Nieuwenhuize, Susan, Dolbois, Aymeric, Blazkova, Kristyna, Hess, Christopher, Low, Larry W. L., Burger, Sibylle, Samson, Natasha, Carney, Tom J., Bartunek, Petr, Nevado, Cristina, Mosimann, Christian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4831813/ https://www.ncbi.nlm.nih.gov/pubmed/27077909 http://dx.doi.org/10.1371/journal.pone.0152989 |
Ejemplares similares
-
Warning regarding hematological toxicity of tamoxifen activated CreERT2 in young Rosa26CreERT2 mice
por: Rossi, Martina, et al.
Publicado: (2023) -
Tamoxifen-Activated CreERT Impairs Retinal Angiogenesis Independently of Gene Deletion
por: Brash, James T., et al.
Publicado: (2020) -
Comparison of Kindlin-2 deficiency-stimulated osteoarthritis-like lesions induced by Prg4(CreERT2) versus Aggrecan(CreERT2) transgene in mice
por: Yao, Qing, et al.
Publicado: (2023) -
Genetic targeting of Purkinje fibres by Sema3a-CreERT2
por: Li, Yan, et al.
Publicado: (2018) -
Generation and characterization of an inducible renal proximal tubule-specific CreERT2 mouse
por: Liang, Shiting, et al.
Publicado: (2023)